New Zealand based nanotechnology company Izon
Science, today announced its sponsorship and participation in the Sydney
2010 International Nanomedicine Conference. The three day nanomedicine conference,
to be held 30 June to 2 July, will bring together researchers and developers
from around the world working in targeted delivery, diagnostics and regenerative
medicine.
"We're delighted to be a sponsor. Nanomedicine is an extremely exciting
and important field. It has the potential to enable early detection and prevention,
and to dramatically improve diagnosis, treatment and follow-up of diseases.
By collaborating with researchers through forums like this we can continue to
develop world leading technology that will help break new ground in healthcare",
says Hans van der Voorn, the Executive Chairman of Izon.
Izon's qNano and qViro instruments combined with the newly launched Variable
Pressure Module (VPM) provide the world's most comprehensive nanoparticle analysis
system.
As part of the sponsorship package Izon is donating a major prize for a fundraising
event at the conference to benefit the Children's Cancer Institute Australia.
The prize package includes the use of a qNano for one year, with consumables,
along with full training in New Zealand and support by Izon technical staff
and the travel package to New Zealand.
Researchers using Izon's nanoparticle analysis system can measure and characterize
virtually all particles including nanoparticles, viruses, bacteria and bioparticles
such as exosomes and liposomes. Particle concentration, electrophoretic mobility,
size and aggregation kinetics can all be analysed. Real time reaction monitoring
allows users to design and test nanoparticle systems by analyzing the changes
in particle properties as various modifications are applied. This is useful
for bio-nano work, drug delivery research or development of diagnostic applications.
Izon's instruments are used across a wide range of scientific fields including
nanomedicine, bionanotechnology, virology, vaccinology, microbiology, gene therapy,
medical research, marine science, aquaculture, chemistry and nanoscience. Current
projects include virus quantitation and analysis, oncolytic viruses, marine
science, drug delivery systems, nanoparticle charge measurement, diagnostic
applications using antibodies and nanoparticles, bioparticle analysis, and controlled
dispensing of particles and biomolecules by count.
The Sydney 2010 International Nanomedicine Conference will be held at the Crowne
Plaza Coogee Beach in Sydney. Izon Chairman Hans van der Voorn will deliver
a brief presentation at the conference dinner on Friday 2 July.